Topics in thoracic oncology: from surgical resection to molecular dissection.
作者信息
Girard Nicolas, Zalcman Gérard
出版信息
Eur Respir Rev. 2013 Jun 1;22(128):101-2. doi: 10.1183/09059180.00000413.
Abstract
摘要
相似文献
1
Topics in thoracic oncology: from surgical resection to molecular dissection.胸科肿瘤学专题：从手术切除到分子剖析
Eur Respir Rev. 2013 Jun 1;22(128):101-2. doi: 10.1183/09059180.00000413.
2
Delivering on the promise of precision cancer medicine.兑现精准癌症医学的承诺。
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
3
Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.放射肿瘤学中的综合分子肿瘤分析：如何将其用于精准医学。
Cancer Lett. 2016 Nov 1;382(1):118-126. doi: 10.1016/j.canlet.2016.01.041. Epub 2016 Jan 29.
4
Preface on application of omics technologies in cancer biology and therapy.组学技术在癌症生物学与治疗中的应用前言
Cancer Lett. 2016 Nov 1;382(1):A1. doi: 10.1016/j.canlet.2016.10.001.
5
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.胸腺癌与肾上腺神经母细胞瘤基因组图谱与预后的差异。
J Natl Cancer Inst. 2019 Nov 1;111(11):1192-1201. doi: 10.1093/jnci/djz027.
6
Updates in Thoracic Surgery and Oncology.
Surg Oncol Clin N Am. 2020 Oct;29(4):xv-xvi. doi: 10.1016/j.soc.2020.07.004. Epub 2020 Aug 11.
7
New ESMO scale ranks mutations as cancer medicine targets.新的欧洲肿瘤内科学会（ESMO）量表将突变列为癌症药物靶点。
Lancet Oncol. 2018 Oct;19(10):e513. doi: 10.1016/S1470-2045(18)30664-8. Epub 2018 Aug 31.
8
Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.基因组分析指导胰腺癌分子靶向治疗的选择。
Cancer Lett. 2015 Jul 10;363(1):1-6. doi: 10.1016/j.canlet.2015.04.009. Epub 2015 Apr 15.
9
Genomics of pancreatic ductal adenocarcinoma.胰腺导管腺癌的基因组学
Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):381-5. doi: 10.1016/s1499-3872(14)60281-2.
10
Personalized Medicine: Genomics Trials in Oncology.个性化医疗：肿瘤学中的基因组学试验
Trans Am Clin Climatol Assoc. 2015;126:133-43.
引用本文的文献
1
The European Respiratory Review: farewell from the editor with confidence for the future.《欧洲呼吸评论》：主编告别，满怀对未来的信心。
Eur Respir Rev. 2015 Dec;24(138):547-9. doi: 10.1183/16000617.0070-2015.
2
Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients.非小细胞肺癌患者生殖系外显子21 EGFR突变，V843I和P848L
Eur Respir Rev. 2014 Sep;23(133):390-2. doi: 10.1183/09059180.00009313.
3
The European Respiratory Review: meeting expectations of respiratory physicians through diversity and quality.《欧洲呼吸评论》：通过多样性与质量满足呼吸科医生的期望。
Eur Respir Rev. 2014 Mar 1;23(131):1-2. doi: 10.1183/09059180.00000614.
本文引用的文献
1
Endobronchial ultrasound in the management of nonsmall cell lung cancer.支气管内超声在非小细胞肺癌治疗中的应用。
Eur Respir Rev. 2013 Jun 1;22(128):169-77. doi: 10.1183/09059180.00001113.
2
Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.癌症中上皮-间充质转化的微环境调控。
Cancer Res. 2012 Oct 1;72(19):4883-9. doi: 10.1158/0008-5472.CAN-12-1223. Epub 2012 Sep 20.
3
Chemotherapy and targeted agents for thymic malignancies.胸腺癌的化疗和靶向药物治疗。
Expert Rev Anticancer Ther. 2012 May;12(5):685-95. doi: 10.1586/era.12.29.
4
Non-small-cell lung cancer.非小细胞肺癌。
Lancet. 2011 Nov 12;378(9804):1727-40. doi: 10.1016/S0140-6736(10)62101-0. Epub 2011 May 10.
5
New driver mutations in non-small-cell lung cancer.非小细胞肺癌中的新驱动基因突变。
Lancet Oncol. 2011 Feb;12(2):175-80. doi: 10.1016/S1470-2045(10)70087-5.
6
Integrating biomarkers into clinical trials: methodological issues for a new paradigm in nonsmall cell lung cancer.将生物标志物纳入临床试验：非小细胞肺癌新范式的方法学问题。
Curr Opin Oncol. 2011 Jan;23(1):106-11. doi: 10.1097/CCO.0b013e3283412eca.
7
Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer.非小细胞肺癌的基因谱分析和表皮生长因子受体靶向治疗。
Eur Respir J. 2011 Jan;37(1):183-93. doi: 10.1183/09031936.00179409. Epub 2010 Oct 28.
8
Update on nonsmall cell lung cancer.非小细胞肺癌的最新进展
Eur Respir Rev. 2010 Sep;19(117):173-85. doi: 10.1183/09059180.00006610.
Zotero 插件